Literature DB >> 31639713

P4 Medicine or O4 Medicine? Hippocrates Provides the Answer.

Clare Fiala1, Jennifer Taher2,3, Eleftherios P Diamandis4,2,3.   

Abstract

BACKGROUND: The term P4 medicine (predictive, preventative, personalized, participatory) was coined by Dr. Leroy Hood of the Institute for Systems Biology to demonstrate his framework to detect and prevent disease through extensive biomarker testing, close monitoring, deep statistical analysis, and patient health coaching.
METHODS: In 2017, this group published the results of their "100 Person Wellness Project." They performed whole genome sequencing and 218 clinical laboratory tests, measured 643 metabolites and 262 proteins, quantified 4616 operational taxonomic units in the microbiome, and monitored exercise in 108 participants for 9 months. The study was also interventional, as members were paired with a coach who gave lifestyle and supplement counseling to improve biomarker levels between each sampling period.
RESULTS: Using this study as a basis, we here analyze the Hippocratic roots and the advantages and disadvantages of P4 medicine. We introduce O4 medicine (overtesting, overdiagnosis, overtreatment, overcharging) as a counterpoint to P4 medicine to highlight the drawbacks, including possible harms and cost.
CONCLUSIONS: We hope this analysis will contribute to the discussion about the best use of limited health-care resources to produce maximum benefit for all patients.
© 2019 American Association for Clinical Chemistry.

Entities:  

Year:  2019        PMID: 31639713     DOI: 10.1373/jalm.2018.028613

Source DB:  PubMed          Journal:  J Appl Lab Med        ISSN: 2475-7241


  1 in total

1.  A study of elective genome sequencing and pharmacogenetic testing in an unselected population.

Authors:  Meagan Cochran; Kelly East; Veronica Greve; Melissa Kelly; Whitley Kelley; Troy Moore; Richard M Myers; Katherine Odom; Molly C Schroeder; David Bick
Journal:  Mol Genet Genomic Med       Date:  2021-07-27       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.